차이
문서의 선택한 두 판 사이의 차이를 보여줍니다.
양쪽 이전 판이전 판다음 판 | 이전 판 | ||
med:preeclampsia_aspirin [2018/12/09 02:38] – [안전성] V_L | med:preeclampsia_aspirin [2022/11/26 03:48] (현재) – [중단시기] V_L | ||
---|---|---|---|
줄 22: | 줄 22: | ||
* [[med: | * [[med: | ||
* [[med: | * [[med: | ||
- | * [[med:당뇨병|]] (1형 혹은 2형) | + | * [[med:diabetes_mellitus]] (1형 혹은 2형) |
* 신장질환 (Renal disease) | * 신장질환 (Renal disease) | ||
* 자가면역질환 (Autoimmune disease) ([[med: | * 자가면역질환 (Autoimmune disease) ([[med: | ||
줄 53: | 줄 53: | ||
=====중단시기===== | =====중단시기===== | ||
- | When should I stop taking low-dose aspirin? | + | |
- | It is very important that you ask your doctor when you should stop taking aspirin, as recommendations may be differ depending on your medical history. | + | 논란이 있다. |
- | + | 36주 이후에는 분만가능성이 있고, 아스피린 복용시 출혈가능성이 증가하여 36주까지만 먹어야 한다는 의견과, 36주 이후에 [[med: | |
- | There are opposing arguments regarding when to discontinue aspirin treatment. Some argue that aspirin should be discontinued at 36 weeks because of the possible bleeding risks associated with delivery. | + | ((There are opposing arguments regarding when to discontinue aspirin treatment. Some argue that aspirin should be discontinued at 36 weeks because of the possible bleeding risks associated with delivery. |
- | Others argue, because most preeclampsia occurs after 36 weeks, that the aspirin may be beneficial to continue through delivery, into the postpartum period. | + | Others argue, because most preeclampsia occurs after 36 weeks, that the aspirin may be beneficial to continue through delivery, into the postpartum period)) |
- | More research is needed, but again, it is imperative you discuss a stopping point with your healthcare professional if you are on a prenatal aspirin regimen. | ||
{{: | {{: | ||
https:// | https:// |